These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33991953)

  • 1. Development and validation of a RPLC-MS/MS method for the quantification of ceramides in human serum.
    Begou OA; Deda O; Karagiannidis E; Sianos G; Theodoridis G; Gika HG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122734. PubMed ID: 33991953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of α-hydroxy ceramides in mice serum by LC-MS/MS: Application to sepsis study.
    Chao Y; Chen X; Shi X; Li N; Gao S; Yang J; Dong X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123764. PubMed ID: 37267800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides.
    Kauhanen D; Sysi-Aho M; Koistinen KM; Laaksonen R; Sinisalo J; Ekroos K
    Anal Bioanal Chem; 2016 May; 408(13):3475-83. PubMed ID: 26922344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
    Ge K; Zheng D; Wang J; Jia W; Zhao A
    Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ceramides and coronary artery stenosis in patients with coronary artery disease.
    Tu C; Xie L; Wang Z; Zhang L; Wu H; Ni W; Li C; Li L; Zeng Y
    Lipids Health Dis; 2020 Jun; 19(1):151. PubMed ID: 32586390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry.
    Dittakavi S; Mahadevan L; Chandrashekar DV; Bhamidipati RK; Suresh J; Dhakshinamoorthy S; Li Z; Baerenz F; Tennagels N; Mullangi R
    Biomed Chromatogr; 2020 May; 34(5):e4790. PubMed ID: 31883352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G
    Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
    Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
    Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide ratios are affected by cigarette smoke but not heat-not-burn or e-vapor aerosols across four independent mouse studies.
    Lavrynenko O; Titz B; Dijon S; Santos DD; Nury C; Schneider T; Guedj E; Szostak J; Kondylis A; Phillips B; Ekroos K; Martin F; Peitsch MC; Hoeng J; Ivanov NV
    Life Sci; 2020 Dec; 263():118753. PubMed ID: 33189821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma.
    Jiang H; Hsu FF; Farmer MS; Peterson LR; Schaffer JE; Ory DS; Jiang X
    Anal Bioanal Chem; 2013 Sep; 405(23):7357-65. PubMed ID: 23857140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy.
    Morita Y; Kurano M; Sakai E; Nishikawa T; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
    J Diabetes Investig; 2020 Mar; 11(2):441-449. PubMed ID: 31580528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive profiling of ceramides in human serum by liquid chromatography coupled to tandem mass spectrometry combining data independent/dependent acquisition modes.
    Luque-Córdoba D; Calderón-Santiago M; Rangel-Zúñiga OA; Camargo A; López-Miranda J; Priego-Capote F
    Anal Chim Acta; 2024 Jan; 1287():342115. PubMed ID: 38182388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction.
    Pan W; Sun M; Wu J; Dong H; Liu J; Gao R; Fang S; Xing L; Hu S; Yu B
    Atherosclerosis; 2020 Jun; 302():8-14. PubMed ID: 32387714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma ceramides are associated with coronary atherosclerotic burden in patients with ST-segment elevation myocardial infarction.
    Pan W; Li L; Sun M; Wang C; Fang S; Yu B
    Int J Cardiol; 2020 Dec; 320():155-160. PubMed ID: 32800902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment.
    Lee TH; Cheng CN; Lee CW; Kuo CH; Tang SC; Jeng JS
    J Formos Med Assoc; 2023 Jan; 122(1):19-28. PubMed ID: 36184387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.
    Mantovani A; Bonapace S; Lunardi G; Canali G; Dugo C; Vinco G; Calabria S; Barbieri E; Laaksonen R; Bonnet F; Byrne CD; Targher G
    Diabetes Metab; 2020 Apr; 46(2):150-157. PubMed ID: 31386900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
    Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
    Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
    Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
    Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.